Patents by Inventor John Kenneth MORROW

John Kenneth MORROW has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-cancer compounds
    Patent number: 9624211
    Abstract: Provided are methods and compositions for the treatment of diseases such as cancer. In certain aspects, compounds which can inhibit Skp2 are provided. Specifically chromenone derivatives are disclosed that have the capability toward reducing differentiation of pluripotent, multipotent or totipotent cells and thus have therapeutic utility in the treatment of a proliferative disease such as cancer.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: April 18, 2017
    Assignee: Board of Regents, The University of Texas System
    Inventors: Shuxing Zhang, Hui-Kuan Lin, Chia-Hsin Chan, John Kenneth Morrow
  • ANTI-CANCER COMPOUNDS
    Publication number: 20160145250
    Abstract: Provided are methods and compositions for the treatment of diseases such as cancer. In certain aspects, compounds which can inhibit Skp2 are provided. Specifically chromenone derivatives are disclosed that have the capability toward reducing differentiation of pluripotent, multipotent or totipotent cells and thus have therapeutic utility in the treatment of a proliferative disease such as cancer.
    Type: Application
    Filed: July 18, 2014
    Publication date: May 26, 2016
    Applicant: Board of Regents, The University of Texas System
    Inventors: Shuxing ZHANG, Hui-Kuan LIN, Chia-Hsin CHAN, John Kenneth MORROW